Similar articles

• Excess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection.

  Filice GA, Nyman JA, Lexau C, Lees CH, Bockstedt LA, Como-Sabetti K, Lesher LJ, Lynfield R. Filice GA, et al. Infect Control Hosp Epidemiol. 2010 Apr;31(4):365-73. doi: 10.1086/651094. Infect Control Hosp Epidemiol. 2010. PMID: 20184420
• [Economic evaluation of a nosocomial infection outbreak of methicillin-resistant Staphylococcus aureus].

  Palau E. Palau E. Enferm Infecc Microbiol Clin. 1992 Nov;10 Suppl 3:62-3. Enferm Infecc Microbiol Clin. 1992. PMID: 1477135 Spanish. No abstract available.
• Cost analysis of outbreaks with Methicillin-resistant Staphylococcus aureus (MRSA) in Dutch long-term care facilities (LTCF).

  van Rijt AM, Dik JH, Lokate M, Postma MJ, Friedrich AW. van Rijt AM, et al. PLoS One. 2018 Nov 26;13(11):e0208092. doi: 10.1371/journal.pone.0208092. eCollection 2018. PLoS One. 2018. PMID: 30475904 Free PMC article.
• Costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control.

  Gould IM. Gould IM. Int J Antimicrob Agents. 2006 Nov;28(5):379-84. doi: 10.1016/j.ijantimicag.2006.09.001. Epub 2006 Oct 11. Int J Antimicrob Agents. 2006. PMID: 17045462 Review.
• Costs of healthcare-associated methicillin-resistant Staphylococcus aureus and its control.

  Gould IM, Reilly J, Bunyan D, Walker A. Gould IM, et al. Clin Microbiol Infect. 2010 Dec;16(12):1721-8. doi: 10.1111/j.1469-0691.2010.03365.x. Epub 2010 Nov 5. Clin Microbiol Infect. 2010. PMID: 20825434 Review.